Hints and tips:
...Unlike their big pharma cousins, they were better known for operational and financial acumen than cutting edge science....
...Lex this week opined on three separate pharma outliers praying for rescues from their “lab rats” — as medical researchers sometimes call themselves....
...The antitrust challenge may force big pharma groups to rethink “pure play” business models. The Lex team is interested in hearing more from readers. Is the FTC right to challenge pharma deals?...
...Auden Mckenzie and Actavis UK increased the price of a 10mg packet by more than 10,000 per cent compared with the original branded version of the drug, the CMA said....
...Reliance has recently invested in healthcare companies including genetics group Strand Life Sciences, after buying a majority stake in pharma sales company Netmeds in 2020....
...(Bloomberg) Open to suggestion Activists swarming corporate Japan have found an ally in Tokyo Stock Exchange boss Hiromi Yamaji, who says more vocal investors could be exactly what Japan Inc needs....
...Nasdaq has won two of the year’s biggest market debuts, the $2.5bn Royalty Pharma IPO and $2.2bn Warner Music listing, and has a third coming up: Airbnb, the accommodation booking group, which plans to sell...
AbbVie’s planned $63bn purchase of the Botox-maker will earn $123m for bank
...Pharma investors have grown to ignore such earnings accretion calculations....
David Tepper’s Appaloosa hedge fund had been instigating for change
...Christine Lemke, co-founder and president of Evidation, a health measurement platform that provides data analytics to tech and pharma companies, says one of Google’s key advantages is it can use unconventional...
...A former Bausch & Lomb executive, the 49-year-old built Allergan through a succession of deals that began in 2013 when the company he ran, then called Actavis, bought Ireland-headquartered Warner Chilcott...
...Companies such as BridgeBio Pharma and Adaptive Biotechnologies have raised hundreds of millions of dollars on Nasdaq this year, in part attracted by the exchange’s biotech index....
...A person close to senior executives at Bristol-Myers said the pharma group had been in touch with several large investors and was confident it would be backed by a majority of its shareholders....
...Pharma companies have typically found it hard to prove the value of their interventions in the field of preventive health....
...This can only be Avantor, whose debt-funded takeover of much larger publicly traded peer VWR saw the pharma group take on eye-watering leverage to pay $1.4bn of dividends to New Mountain Capital....
...Actavis Holdco U.S., Inc.; Actavis Pharma, Inc.; Ascend Laboratories, LLC; Apotex Corp.; Dr....
...The two largest overseas pharma companies in China by sales, AstraZeneca and Pfizer, both said China sales rose 24 per cent in the last quarter compared to the same period last year....
...According to Silvana van Schaik, manager for healthcare and chemicals at research provider Sustainalytics, the 2016 outcry persuaded some pharma companies, led by Ireland-headquartered Allergan, to commit...
...The firm’s original investment in Allergan was a money-spinner, reaping gains of $2.3bn before the company agreed a sale to Actavis....
...Actavis to keep prices artificially high....
...However shares in the $84bn US-listed Irish pharma group were held back by the sharp-off in Teva....
...It is the second time in recent months that the CMA has said it would investigate Actavis over pricing....
...Teva could use a similar shot in the arm, after deciding to spend nearly $40bn in cash and shares on Actavis, another generic pharma specialist, in 2015....
...Read more: Consumer drugs do not always work for big pharma Image source: Bloomberg...
International Edition